INK4A is a G1-speci®c cell cycle inhibitor which maps to human chromosome 9p21, a region frequently mutated or deleted in cancer cell lines and primary tumors. In glioblastomas the frequency of homozygous deletions is 40 ± 70% making it one of the most common mutations in this tumor type. We have analysed the signi®cance of the loss of this gene in gliomas by introducing the cDNA for p16
Introduction
The mammalian cell cycle is regulated by a family of homologous serine/threonine protein kinases known as cyclin dependent kinases (CDKs) (Hunter and Pines, 1994) . The CDKs are positively regulated by the cyclins. D-type cyclins activate CDK4 and CDK6 to drive the cell through the restriction point in late G1 (Matsushime et al., 1992; Xiong et al., 1992; Bates et al., 1994; Meyerson and Harlow, 1994) . A critical substrate for CDK 4 ± 6/D-type cyclins is pRb (Weinberg, 1995) , which in its active hypophosphorylated form binds to and negatively regulates transcription factors needed for entry into S-phase. Phosphorylation of pRb by active CDK4 ± 6 leads to its inactivation and allows for G1-S transition. p16 INK4A is a G1 speci®c cell cycle inhibitor which negatively regulates CDK4 and CDK6 by binding in competition with D-type cyclins (Xiong et al., 1993) . The gene for p16 INK4A is located on human chromosome 9p21, a region frequently mutated or deleted in human cancer cell lines (Kamb et al., 1994; Nobori et al., 1994) and, to a lesser extent, in primary tumors, including pancreatic carcinomas, gliomas, esophageal carcinomas, non-small cell lung carcinomas and soft tissue sarcomas (Hirama and Koeer, 1995; Kamb, 1995) . Mice carrying targeted deletions of the p16 INK4A locus developed spontaneous tumors at an early age and are highly sensitive to carcinogenic treatment (Serrano et al., 1996) . In addition, INK4A 7/7 primary mouse embryo ®broblasts (MEF) have altered growth properties in culture. They proliferate more rapidly and to higher cell densities than normal MEFs and show a high colony-formation eciency in soft agar. Serial passage of INK4A 7/7 MEFs results in a constant and rapid growth rate with no detectable senescent phase even at high population doubling levels (PDL), whereas normal MEFs reach senescence at PDL equal to around 12. These data suggest a role for p16 INK4A in density dependent growth regulation and cellular senescence.
In gliomas the main type of inactivation of the p16 INK4A locus is homozygous deletions (Jen et al., 1994; He et al., 1995; Nishikawa et al., 1995; Sonoda et al., 1995) which mainly occur rather late during glioma progression with a high prevalence in WHO grade 3 and 4 tumors . The frequency of deletions in glioma cell lines is 70 ± 90% (Kamb et al., 1994; Nobori et al., 1994; He et al., 1995) and in glioblastoma tissues (WHO grade 4) 40 ± 70% (Jen et al., 1994; Schmidt et al., 1994; Dreyling et al., 1995) .
In the present study we have introduced an inducible p16
INK4A expression vector into a human glioma cell line that lacks endogenous expression of p16 INK4A due to homozygous deletion of the gene. Induction of p16 INK4A expression was accompanied by a change in phenotype resembling that of senescent cells.
Results

Expression of p16
INK4A causes a G1 arrest in U-1242 MG glioma cells
Since p16
INK4A is expected to be growth inhibitory and since we wanted to establish stably expressing clones, we chose to use the tetracycline repressable vector system (Gossen and Bujard, 1992) . The human glioma cell line U-1242 MG which has a homozygously deleted CDKN2 locus, as found by Southern blot analysis (not shown), was used for transfection. Two clones exhibiting a strong p16
INK4A expression which appeared only in the absence of tetracycline, were isolated and referred to as c1.A1 and cl.C12.
Expression of p16
INK4A mRNA was demonstrated by Northern analysis (Figure 1 ) and expression of the corresponding protein was analysed by immunoprecipitation of metabolically labelled cells and SDS polyacrylamid gel electrophoresis (Figure 2a) . Both clones exhibited a strong p16
INK4A expression (50 ± 70-fold induction of mRNA) which was almost completely suppressed in the presence of tetracycline.
Having demonstrated the inducible expression of p16 INK4A in the two selected clones, we next examined the eect of the protein on the downstream target proteins, CDK4, CDK6 and pRb; p16
INK4A binds to and inhibits the activity of the serine/threonine protein kinases CDK4 and CDK6 (Xiong et al., 1993) preventing them from phosphorylating pRb; further progression into S-phase is thereby inhibited. We investigated complex formation between p16
INK4A and CDK4 and 6 by immunoprecipitation of the CDK:s followed by Western blotting for the detection of p16
INK4A
. Data are shown for cl.A1 (Figure 2c ). p16
INK4A could be coprecipitated with CDK6 in the absence of tetracycline (and to a lesser extent also in the presence of tetracycline due to a small leakage in the expression vector system) but was consistently undetectable when immunoprecipitating with CDK4 antibodies. Immunoprecipitation of CDK4 showed a marked decrease in the level of CDK4 in cells expressing p16
( Figure 2d ) compared to cells devoid of p16
while no such downregulation could be seen for CDK6 (Figure 2d ). This could be the explanation for the inability to detect p16 INK4A in the CDK4 precipitates. We should also expect an eect on the phosphorylation status of pRb in cells expressing p16
. Analysis by SDS ± PAGE of immunoprecipitated pRb showed this to be the case since there was a marked shift in electrophoretic mobility of pRb precipitated from cells grown in the absence of tetracycline, in agreement with the presence of an hypophosphorylated protein (Figure 2b ). There was no eect of tetracycline on the electrophoretic mobility of pRb immunoprecipitated from untransduced control cells.
Next we investigated if induced expression of p16 INK4A had any biological eect on glioma cells. Sparsely seeded cell cultures were therefore grown in the presence or absence of tetracycline for 5 days before they were counted. Clearly, p16
INK4A expression had an inhibitory eect on cell proliferation with an approximately 37% reduction in cell number for cl.A1 and 26% for cl.C12 at day 5 after removal of tetracycline (Figure 3) In order to ®nd out whether the p16 INK4A expressing cells had an increased rate of apoptosis, we performed a TdT-mediated dUTP-biotin nick end labeling (TUNEL) staining which detects cells undergoing DNA fragmentation and thus is an indicator of apoptosis (Gavrieli et al., 1992) . The amount of apoptotic cells was not increased in the p16 INK4A expressing cells as compared with the same clone grown in the presence of tetracyclin (not shown). Since p53 is an important player in the apoptotic pathway we decided to explore the status of the p53 gene in the cell line U-1242 MG. Polymerase chain reaction (PCR) followed by direct sequencing of exons 5 to 8 of the p53 gene, revealed a mutation in exon 5 at codon 175. This mutation leads to a change from arginine to histidine which has been shown to result in a denatured structure of the p53 protein (Gannon et al., 1990; Hinds et al., 1990; Raycroft et al., 1991; Stephen and Lane, 1992) . The fact that p53 is mutated in these cells might in¯uence the result; others have demonstrated the importance of a wild type p53 protein in apoptosis induction (Yonhish Rouach et al., 1991; Shaw et al., 1992; Debbas and White, 1993; Lowe et al., 1994) . INK4A whereas cells that remained small, did not. A recent report has shown that senescent human ®broblasts, in contrast to pre-senescent cells or quiescent cells, express a b-galactosidase only detectable at pH 6.0 (Dimri et al., 1995) , was to some extent reversible. Thus, after suppressing p16
INK4A expression by tetra- dependent senescence phenotype in U-1242 MG glioma cells. Senescence could also be the explanation for the decreased levels of CDK4 in these cells (Figure 2d ) when grown in the absence of tetracycline, as it has been reported that CDK4 is downregulated in senescent cells (Lucibello et al., 1993) .
Discussion
In this study we have used an inducible vector system to express p16 INK4A in the human glioma cell line U-1242 MG, which has a homozygous deletion of the CDKN2 gene. A number of assays were used to show that the cells, when transcription of the transduced cDNA was induced, expressed a high amount of functionally active p16 INK4A consistently failed to incorporate BrdU. The growth inhibitory eect was less obvious when cell proliferation was monitored on mass cultures by cell counts. Such a discrepancy may be explained by the progressive accumulation of revertants, which occurred as a result of de®ciency in the expression system. The growth inhibitory eect of stably transfected p16
INK4A is consistent with the results from transfection studies (Okamoto et al., 1994; Arap et al., 1995; Lukas et al., 1995; Serrano et al., 1995; Wu et al., 1996) and adenovirus-mediated gene transfer of p16
INK4A (Fueyo et al., 1996) on primary cells and cultured cell lines.
The decrease in cell number in p16 INK4A expressing cultures was not due to apoptosis. By using the TUNEL method we found that there was no
INK4A can block apoptosis in dierentiating myocytes (Wang and Walsh, 1996) , and observations in other cell types have shown that p53 dependent and independent apoptosis can be inhibited by overexpression of pRb (Haas Kogan et al., 1995; Haupt et al., 1995) possibly through sequestering of E2F. Several studies have shown the importance of p53 in the apoptotic pathway in transformed cells (Yonish Rouach et al., 1991; Shaw et al., 1992; Debbas and White, 1993; Lowe et al., 1994) ; since the p53 gene is mutated in the U-1242 MG cell line, the cells are supposedly refractory to any p53-dependent apoptotic pathway; the relationship between p53 and p16
INK4A
, if any, in the induction of apoptosis in these cells cannot be immediately assessed.
The morphological change that occurred when p16
INK4A was expressed in U-1242 MG glioma cells led us to investigate the possibility that these immortal cells might have been forced to enter senescence. This alteration in cell morphology is in agreement with the results from the adenoviraly mediated genetransfer of p16
INK4A into three dierent human glioma cell lines (Fueyo et al., 1996) positive; cell enlargement and inability to proliferate at subcon¯uent cell densities despite the presence of serum are well known correlates to cellular senescence. By using the SA-b-gal staining, which has been shown to be speci®c for senescent cells (Dimri et al., 1995) , we could subsequently show a high degree of SA-b-gal in enlarged cells. The link between senescence and the expression of p16 INK4A has been suggested by several authors. In primary human ®broblasts the level of p16 INK4A is very low, but the RNA and protein accumulate to high levels in senescent cells (Hara et al., 1996) . The p16 INK4A knock-out mouse is prone to develop tumors at an early age and mouse embryo ®broblasts (MEFs) from these mice show a high colony-formation eciency and no sign of senescence phase at population doubling levels (PDLs) far beyond when normal cells enter senescence (Serrano et al., 1996) . Investigation of the role for p16
INK4A in inducing senescence in human head and neck keratinocytes revealed a correlation between the loss of p16 INK4A expression and keratinocyte immortality in several keratinocyte cell lines (Loughran et al., 1996) showed that the cell cycle block in senescent cells is not completely irreversible; when senescent ®broblasts were fused to SV40 transformed cells, DNA synthesis was induced in the senescent nuclei in the heterodikaryons (Stein et al., 1982) , most likely as an eect of SV40 large T antigen. In senescent human diploid ®broblasts the p16
level is nearly 40-fold increased in comparison to early passage cells (Alcorta et al., 1996) . The increased p21 level in cells entering senescence is decreased and followed by the upregulation of p16
, and the majority of the CDK4 and CDK6 kinases are shown to be in complex with p16 
Materials and methods
Cell lines and culture conditions
The human cell line U-1242 MG used in the present investigation originates from a tumor diagnosed as a glioblastoma multiforme (Lubitz et al., 1980; Bongcam Rudlo et al., 1991) . The original cells were grown as monolayer cultures in Eagle's minimum essential medium (MEM) (GIBCO, Life technologies Ltd. Paisley, Scotland) supplemented with 10% foetal bovine serum (FBS) (GIBCO, Life technologies Ltd. Paisley, Scotland) and antibiotics (100 units of penicillin and 50 mg of streptomycin per ml). Normal human foreskin ®broblasts, lines 1064 SK and AG 1523 were obtained from the Human Genetic Mutant Cell Repository (Camden, NJ, USA) and grown in the same medium as the cells above.
Plasmid constructions
The human p16
INK4A cDNA (Serrano et al., 1993) (kindly provided by Dr D Beach, Cold Spring Harbor) was inserted into the vector pBluescript SK-between the EcoRI and XhoI restriction enzyme sites. In order to insert the p16 INK4A cDNA into the EcoRI site of pUHD10-3 (Gossen and Bujard, 1992) the cDNA was modi®ed to create an EcoRI site at the XhoI site using a XhoI ± EcoRI adaptor (Stratagene) and standard techniques. The modi®ed p16 INK4A EcoRI fragment was excised and puri®ed using a QIAEX DNA Gel Extraction kit (Qiagen GmbH) and ligated into pUHD10-3 which had previously been cleaved with EcoRI and phosphatased at 168C over night. Competent JM109 bacterial cells (Promega) were transformed with the ligation mix and plated on ampicillin plates. Transformants were picked and expanded and plasmids were analysed by restriction enzyme cleavage.
Transfection of U-1242 MG glioma cells
The following expression plasmids were used for transfections: (a) pUHD15-1 coding for the tTA transcription factor; (b) pUHD10-3:p16 INK4A , containing the complete human p16 INK4 cDNA coding sequence inserted, as described above, in the EcoRI site of pUHD10-3 in sense orientation downstream of a hCMV minimal promoter with heptamerized tet-operators (pUHD15-1 and pUHD10-3 plasmids were obtained from Dr H Bujard, Heidelberg); (c) the retroviral vector RD2 containing the neomycin resistance gene (obtained from Dr L Hellman, Uppsala). Subcon¯uent U-1242 MG glioma cells grown in 100 mm dishes were washed three times with OPTIMEM (GIBCO) and incubated in 5 ml of the same serum-free medium. To each culture a Lipofectin (GIBCO)/DNA mixture (20 mg Lipofectin/10 mg pUHD15-1, 10 mg pUHD10-3:p16
INK4A and 1 mg RD2) was added, and the cells were incubated for 14 h at 378C. Thereafter the medium was changed to routine medium and 2 mg/ml tetracycline was added. The cells were further incubated for 48 h before 0.8 mg/ml G418 (Geneticin, GIBCO) was added to the medium. Neomycin resistant cell clones were seen after 14 days. When the clones consisted of 200 ± 400 cells, they were transferred to new dishes for subcultivation and analysis. The clones were at all times routinely grown in the presence of G418 (0.4 mg/ml) and tetracycline (2 mg/ml).
Northern blot analysis
For screening, cells from each clone were grown for 3 ± 5 days in the presence and absence of tetracycline before harvest. Total cellular RNA was isolated according to the protocol by Chomczynski and Sacchi 1987) . Fifteen mg of RNA from each sample were fractionated on a 1% agarose gel containing 2.2 M formaldehyd, and transferred to nitrocellulose ®lters (Hybond-C extra, Amersham International, Amersham, UK). Filters were baked at 808C under vacuum for 2 h. A 32 P-labeled probe of the p16 INK4A EcoRI ± XhoI fragment described above was prepared using a commercially available kit for random priming (Megaprime, Amersham International, Amersham, UK). Hybridization was carried out under high stringency conditions (50% formamide) at 428C over night. After high stringency washing at 608C the ®lters were exposed to phosphorimaging plates (FUJI-type Bas-3) for 1 ± 2 days and after that to Kodak XAR5 ®lms (Eastman-Kodak, Rochester, NY, USA) for 5 ± 14 days. The phosphorimaging plates were processed in the program Fujix Bas 2000 EWS Software version 2.1 and the results were printed by Fujix Bas HG-printer HG P2100-B. To assure equal loading the ®lters were stripped and rehybridized with a probe for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) (Tso et al., 1985) . Band intensities were measured in the phosphorimager.
Southern blot analysis
U-1242 MG, AG 1523 and 1064 SK cells were grown in Eagle's MEM and harvested. Chromosomal DNA was prepared by adding lysis buer (50 mM Tris-HCl, pH 8.0, 100 mM EDTA, 100 mM NaCl, 1% SDS) and proteinase K (0.4 mg/ml) to the cell pellets. After incubation at 378C over night the samples were chloroform/phenol extracted and ethanol precipitated. DNA was cleaved with EcoRI, separated on a 0.7% agarose gel, denatured and transferred to nitrocellulose ®lters (Hybond-C extra, Amersham International, Amersham, UK). Filters were baked at 808C under vacuum for 2 h. Hybridization and washing were performed as described above.
Immunoprecipitation and Western blot analysis
Cell cultures were grown in routine media in the presence and absence of tetracycline for 5 days in 100 mm dishes. For radiolabeled extracts, the cells were preincubated in methionine-free, serum-free MCDB 104 medium before they were metabolically labelled for 2 ± 3 h with 200 mCi/ml of [
35 S]methionine (Amersham) in the same medium. The cells were washed twice with ice-cold phosphate buered saline and collected by scraping into lysis buer (100 mM Tris, pH 8.0, 0.15 M NaCl, 1% sodium-deoxycholate, 300 mM vanadate (Na 3 VO 4 ), 1% Trasylol (Bayer) and 1 mM phenylmethylsulfonyl¯uoride (Sigma)) and lysed on ice for 30 min. Nuclei were removed by centrifugation at 15 0006g for 15 min, and lysates were precleared by incubating with normal rabbit serum (Dakopatts) and protein-A-sepharose beads (50% slurry in phosphate buered saline, Kabi-Pharmacia, Uppsala, Sweden) for 45 min at 48C followed by centrifugation at 15 0006g for 5 min. Lysates were added antibodies against pRB (PMG3 245, C36, XZ104 and XZ55, Pharmingen)+secondary antibody (rabbit Ig to mouse Ig), p16
INK4A (M-156, Santa Cruz Biotechnology), CDK4 (C-22, Santa Cruz Biotechnology) and CDK6 (C-21, Santa Cruz Biotechnology) respectively as well as protein-A-sepharose and were incubated for 2 ± 3 h at 48C. Immunoprecipitates were washed four times with lysis buer. The proteins were extracted by addition of SDS-sample buer (4% SDS, 0.2 M Tris-HCl pH 8.8, 0.5 M sucrose, 5 mM EDTA pH 8.0, 0.01% bromphenol blue, 2% 2-mercapto-ethanol) followed by incubation at 958C for 4 min. Samples were separated on SDS-polyacrylamide gels.
For Western blot analysis the immunoprecipitated proteins were transferred to Hybond-ECL membranes (Amersham), followed by incubation with primary antibodies as above. After incubation with HRP-coupled secondary antibodies, the ECL Western blotting analysis system (Amersham) was used for detection.
Assay for cell proliferation
The cells were seeded at 5610 4 cells per 35 mm-dish in Eagle's MEM, containing 10% FCS. They were grown either in the presence of absence of tetracycline (2 mg ml) in duplicate dishes. The cell number per dish was determined at day 5 by using a Coulter counter (Coulter Electronics, Herpendon, UK).
Double immuno¯ourescence analysis of p16
INK4 and BrdU or p16 INK4A and vimentin Cells were seeded on coverslips at a density of 2610 4 cells per 35 mm-dish in Eagle's MEM, 10% FBS, in the absence and presence of tetracycline (2 mg/ml). After 4 days, BrdU (Amersham) was added to a ®nal concentration of 10 mM and the cells were incubated for 24 h before they were ®xed in ice-cold methanol:acetone 1:1 for 10 min. Cells were rehydrated in PBS and incubated with primary rabbit antibody against p16
INK4A (M-156, Santa Cruz Biotechnology) diluted 1:100, at 48C overnight. After three washes in PBS the coverslips were incubated with a mouse monoclonal antibody to BrdU (Amersham) TdT-mediated dUTP-biotin nick end labeling (TUNEL)
Cells seeded on coverslips as above were ®xed in 1% formaldehyde for 15 min at room temperature followed by 70% ethanol for 1 h on ice. The U-1242 MG cells used as positive control were incubated with DNase (1U/50 ml PBS) at 378C for 15 min. The coverslips were rinsed in dH 2 O and incubated in terminal transferase buer supplemented with 1 mM cobalt chloride, 0.2 U/ml terminal transferase, 0.01 nmol/ml of biotinylated-16-dUPT (Boehringer Mannheim) in humid atmosphere at 378C for 60 min. The reaction was terminated by transferring the slides to a buer containing 300 mM sodium chloride and 30 mM sodium citrate for 15 min at room temperature. The coverslips were then rinsed three times in dH 2 O and three times in phosphate buered saline before incubation with ABComplex (Dakopatts) diluted 1:100 for both A and B in phosphate buered saline with 0.1% bovine serum albumin at room temperature for 30 min. After rinsing in phosphate buered saline the immunoreaction was visualized by incubation in AEC for about 25 min at room temperature followed by washing in dH 2 O and mounting with Immumount (Shandon). Cells were viewed in an Olympus IMT-2 phase-contrast microscope.
Senescence-Associated b-Galactosidase (SA-b-gal) staining Cells were grown for 5 ± 7 days in the absence and presence of tetracycline. Late passage human ®broblasts AG 1523
and early passage human ®broblasts SK 1064 were used as positive and negative controls, respectively. The method for senescence-associated b-galactosidase (SA-b-gal) staining was performed as described (Dimri et al, 1995) . The experiment was repeated twice, and at least 550 cells were counted each time. Cells were viewed in an Olympus IMT-2 phase-contrast microscope and photographs were taken with an Olympus OM10 camera using a 100 ASA Fuji color ®lm, processed and printed as above. In order to examine the reversibility of the senescence phenotype induced by p16 INK4 , the cells were seeded sparsely and grown for 5 days in the absence of tetracycline followed by 4 days incubation in media containing tetracycline. Control cells were grown either in the presence or in the absence of tetracycline for 9 days.
In vitro thermo cycling and solid-phase sequencing of the p53 gene
The status of p53 gene in the cell line U-1242 MG was determined by ampli®cation of exons 5 ± 8 of the p53 in a multiplex nested polymerase chain reaction (PCR) on chromosomal DNA followed by solid-phase sequencing. The methods used have been described (Hedrum et al., 1994) . DNA from the normal human ®broblast cell line AG 1523 was also sequenced and used as a reference for the U-1242 MG sequence.
